Safety and Efficacy of Sublingual Immunotherapy for Allergic Rhinitis Due to Artemisia Annua
Clinical trial NCT03990272 · COMPLETED
Trial details
- NCT number
- NCT03990272
- Sponsor
- Beijing Tongren Hospital
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2017-10-22
- Enrollment
- 702
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.